Document:

<PAGE>

                      AMENDMENT TO AGREEMENT BETWEEN ONCURE
                TECHNOLOGIES CORP. AND KAUFMAN FAMILY LTD. TRUST

         THIS AMENDMENT (this "Amendment"), dated this 28 day of December, 2001
(the "Effective Date"), by and among, KAUFMAN FAMILY LTD. TRUST, a ________
trust (the "Kaufman Trust"), Howard Kaufman, an individual ("Kaufman"), and
ONCURE TECHNOLOGIES CORP., a Florida corporation ("OnCure), amends the agreement
titled Agreement Between U.S. OnCure Technologies Corp. and Howard Kaufman,
dated as of June 28, 2001, between Howard Kaufman and OnCure (the "Agreement").
As used in this Amendment, unless otherwise defined herein, terms defined in the
Agreement shall have the meaning set forth therein when used herein.

                              W I T N E S S E T H:

         WHEREAS, Kaufman Trust is the beneficial owner of 175,000 shares of
common stock, $0.001 par value per share, of OnCure (the "Common Stock");

         WHEREAS, pursuant to the terms of the Agreement, Kaufman Trust has the
right to require OnCure to purchase an aggregate of 125,000 shares of Common
Stock owned by Kaufman Trust at a purchase price equal to $2.00 per share (the
"Put Right");

         WHEREAS, Kaufman Trust has agreed to forbear from exercising its Put
Right with respect to one half of the shares of Common Stock subject thereto (or
62,500 shares);

         WHEREAS, pursuant to the terms of the Agreement, Kaufman Trust is
entitled to receive interest payments on the value of the Put Right (i.e.,
$250,000) at a per annum rate equal to ten percent (10%);

         WHEREAS, Kaufman and OnCure desire to substitute Kaufman Trust for
Kaufman under the Agreement; and

         WHEREAS, the parties desire to amend the Agreement as set forth herein.

         NOW, THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements contained herein, and for other good and valuable
consideration, the adequacy and receipt of which are hereby acknowledged, the
parties hereto, intending to be legally bound, hereby agree as follows:

SECTION 1.1 Parties.

         (1) The Agreement is hereby amended by deleting each reference to
"Kaufman" and inserting in lieu thereof "Kaufman Trust."

<PAGE>

SECTION 1.2 Put Right.

         (1) Exercise. On the Effective Date, Kaufman Trust shall deliver stock
certificates representing shares of Common Stock, duly endorsed for transfer or
accompanied by duly executed stock powers, free and clear of all Encumbrances
(as defined below), to OnCure upon delivery by OnCure of an amount in cash equal
to $125,000, payable by certified funds, bank check or wire transfer. In the
event that the stock certificates delivered by Kaufman Trust represent an amount
of Common Stock in excess of 62,500 shares of Common Stock, OnCure shall issue
new stock certificates to Kaufman Trust in an amount equal to such excess
shares. As used in this Amendment, "Encumbrance" shall mean any claim, lien,
pledge, option, charge, easement, security interest, deed of trust, mortgage,
encumbrance or other right of third parties, whether voluntarily incurred or
arising by operation of law.

         (2) Future Exercise. Kaufman Trust shall have the right to require
OnCure to purchase the remaining 62,500 shares of Common Stock underlying the
Put Right, at a purchase price equal to $2.00 per share, in accordance with the
schedule set forth below (the "Monthly Payment").

   -------------------------------------------------------------------------

   DATE                 AMOUNT OF SHARES TO BE PURCHASED     MONTHLY PAYMENT
   ----                 --------------------------------     ---------------
   -------------------------------------------------------------------------
   January 15, 2002                  5,208                      $10, 146
   -------------------------------------------------------------------------
   February 15, 2002                 5,208                       $10,146
   -------------------------------------------------------------------------
   March 15, 2002                    5,208                       $10,146
   -------------------------------------------------------------------------
   April 15, 2002                    5,208                       $10,146
   -------------------------------------------------------------------------
   May 15, 2002                      5,208                       $10,146
   -------------------------------------------------------------------------
   June 15, 2002                     5,208                       $10,146
   -------------------------------------------------------------------------
   July 15, 2002                     5,208                       $10,146
   -------------------------------------------------------------------------
   August 15, 2002                   5,208                       $10,146
   -------------------------------------------------------------------------
   September 15, 2002                5,208                       $10,146
   -------------------------------------------------------------------------
   October 15, 2002                  5,208                       $10,146
   -------------------------------------------------------------------------
   November 15, 2002                 5,208                       $10,146
   -------------------------------------------------------------------------
   December 15, 2002                 5,208                       $10,146
   -------------------------------------------------------------------------

         (3) Procedure for receiving the Monthly Payment. OnCure shall remit the
Monthly Payment to Kaufman Trust on the fifteenth (15th) day of each month, but
if such day is not a Business Day (as defined in Section 1.03 (b), below), then
on the next succeeding Business Day to occur after such date, provided that: (i)
OnCure receives notice from Kaufman Trust of its intent to exercise its Put
Right for that month; and (ii) Kaufman Trust delivers stock certificates to
OnCure which represent the amount shares of Common Stock to be acquired and
which are duly endorsed for transfer or accompanied by duly executed stock
powers, free and clear of all Encumbrances. Notice shall be deemed given by
Kaufman Trust under this Amendment when it is received by OnCure either
personally or by mail, facsimile or overnight courier on or before the tenth
(10th) day

                                        2
<PAGE>

of the month. If mailed, notice shall be deemed to be effective three (3) days
after deposited in registered or certified mail with postage thereon prepaid
addressed when mailed to OnCure at:

                  OnCure Technologies Corp.
                  7450 East River Road, Suite 3
                  Oakdale, CA 95361
                  Attn: Jeffrey A. Goffman
                  Fax: (209) 848-5730

If given in any other manner, such notice shall be deemed to be effective (a)
when given personally, (b) when given by facsimile (if followed by a copy
delivered by registered or certified mail) or (c) one (1) day after given to a
recognized national overnight courier to be delivered.

         (4) Forbearance. Kaufman Trust, in its sole and absolute discretion,
shall have the right to forbear from exercising its Put Right, and receiving the
corresponding Monthly Payment, in any monthly period. In the event that Kaufman
Trust chooses not to exercise its Put Right in any month, Kaufman Trust shall
have the right to require OnCure to purchase such shares of Common Stock in any
subsequent monthly period up and until the Termination Date.

SECTION 1.3 Interest Payments.

         (1) On the Effective Date, OnCure shall pay an amount in cash equal to
$24,362.41, payable by certified funds, bank check or wire transfer, for all
accrued and unpaid interest owed by OnCure to Kaufman Trust as of the Effective
Date, including without limitation, all interest payments owed to Kaufman Trust
pursuant to the Agreement.

         (2) For the period commencing on the Effective Date and continuing
through the Termination Date (as defined in Section 1.05, below), OnCure shall
pay interest ("Interest") on the Value (as defined below) at a per annum rate
equal to ten percent (10%). Interest on the Value shall accrue from the
Effective Date until the Termination Date and shall be computed on the basis of
a 360-day year comprised of twelve 30-day months. Interest shall be paid on the
first day of each month; provided that, if any such day shall not be a Business
Day (as defined below), Interest shall be payable on the next succeeding
Business Day to occur after such date, beginning on January 1, 2002. Interest
shall be payable in cash by certified funds, bank check or wire transfer. As
used in this Amendment, "Value" shall mean the number shares of Common Stock
that Kaufman Trust has the right to require OnCure to purchase multiplied by
$2.00 and "Business Day" shall mean any day other than a Saturday, Sunday or
other day on which commercial banks in the State of New York are authorized or
required by law or executive order to close.

SECTION 1.4 Event of Default.

         (1) Kaufman Trust may terminate this Amendment and accelerate all of
the payments required to be made hereunder, upon the occurrence of the following
event ("Event of Default"):

                                       3
<PAGE>

              (i) Any failure by OnCure to make any Monthly Payment required to
         be made hereunder, on or before the date on which such payment is
         required to be made, provided that such failure continues unremedied
         for a period of ten (10) days.

SECTION 1.5 Termination.

         (1) Except in the Event of Default, Kaufman Trust's right to receive
any payment to be made hereunder shall terminate on June 1, 2003 (the
"Termination Date").

SECTION 1.6 Miscellaneous.

         (1) This Amendment shall be interpreted and enforced in accordance with
the laws of the State of Florida or New York at the option of Kaufman Trust
without regard to its conflicts of law principles.

         (2) This Amendment may be executed in one or more counterparts and by
one or more parties to any counterpart, each of which shall be deemed an
original and all of which together shall constitute one and the same agreement.
A signed counterpart provided by way of facsimile shall be binding upon the
parties hereto as an original signed counterpart.

         (3) In the Event of Default, Kaufman Trust, at its option, shall have
the right to enforce this Agreement in Florida as set forth in paragraph 12 of
the Agreement or obtain a confession of judgment in New York to which OnCure
consents in accordance with the application of New York law.

         (4) The Agreement has not been amended except as expressly set forth
herein, and the Agreement shall remain in full force and effect as constituted
as of the date hereof.

                                       4
<PAGE>

         WITNESS WHEREOF, Kaufman Trust, Kaufman and OnCure have caused this
Amendment to be executed, all as of the day and year first above written.

KAUFMAN TRUST LTD. TRUST               ONCURE TECHNOLOGIES CORP.

By: /s/ Howard Kaufman                 By: /s/ Jeffrey A. Goffman
    ------------------                     ----------------------
Name: Howard Kaufman                       Name:  Jeffrey A. Goffman
      Trustee                              Title: Chief Executive Officer

      _____________________________
      Howard Kaufman

                                       5<PAGE>

                  CONVERSION OF NOTES AND OPTION TO SELL STOCK
                          IN ONCURE TECHNOLOGIES CORP.

         This Agreement (this "Agreement") is made to be effective as of May 10,
2001 ("Effective Date"), by and among OnCure Technologies Corp., a Florida
corporation (the "Corporation"), John J. Fuery, M.D. (the "Note Holder"), and
Continuum Capital Partners, Inc. ("Continuum").

                                    RECITALS

         A. The Corporation owns or controls entities which provide radiation
oncology treatments to cancer patients.

         B. The Note Holder owns three promissory notes of the Corporation: the
note dated 6-10-99 in the original principal amount of $300,903.25 (principal
balance $300,903.25), the note dated 9-01-00 in the original principal amount of
$189,000.00 (approximate principal balance $143,171), and the note dated
12-18-98 in the original principal balance of $735,000.00 (approximate principal
balance $586,187) (hereinafter referred to collectively as the "Promissory
Note").

         C. The Corporation owes the Note Holder certain additional expenses, as
shown on Exhibit A attached hereto and incorporated herein, in the amount of
$130,150.49 ("Expenses").

         D. The Corporation and the Note Holder wish to convert the note dated
12-18-98 in the original principal balance of $735,000.00 and Expenses to one
cent par value common stock of the Corporation ("Converted Common Stock") at the
rate of $2.00 per share subject to the terms and conditions set forth in this
Agreement, including inter alia Note Holder's right to reinstate said Promissory
Note in the event certain conditions are not satisfied.

         E. Note Holder wishes to grant and Continuum wishes to obtain an option
to call all of the Note Holder's Converted Common Stock at a price of $2.25 per
share, subject to the terms and conditions set forth in this Agreement.

                                    AGREEMENT

         NOW, THEREFORE, the parties hereto hereby agrees as follows:

1.       CONVERSION. Note Holder agrees to convert the note dated 12-18-98 in
         the original principal balance of $735,000.00 and Expenses
         (approximately $716,338) to one cent par value common stock of the
         Corporation ("Converted Common Stock") at the rate of $2.00 per share
         (approximately 358,169 shares), subject to the conditions set forth in
         this Agreement. The exact amount subject to conversion shall be
         determined upon satisfaction of all conditions precedent to close of
         escrow. Subject to review by the Note Holder's and the Corporation's
         respective tax advisors, for purposes of tax reporting, the Corporation
         shall issue its 1099 to Note Holder, for any portion of the Converted
         Common Stock for

<PAGE>

         which a 1099 is due, at a value no greater than the market closing
         price on the day of issuance of the Converted Common Stock, less a
         fifty percent (50%) block discount.

2.       ESCROW.

         a.   Note Holders' note dated 12/18/98 in the original principal
              balance of $735,000.00 shall be deposited with the Escrow Agent,
              along with this Agreement, pending exercise by Cotinuum of its
              Call Option pursuant to this Agreement.

         b.   Interest only will be paid monthly on the remaining balance of the
              note dated 12-18-98 in the original principal balance of
              $735,000.00 at its stated rate and on the Expenses at nine (9)
              percent per annum, and all other terms and conditions of the note
              dated 12-18-98 in the original principal balance of $735,000.00
              shall remain in effect until conversion and purchase pursuant to
              Continuum's Call Option.

         c.   If Continuum does not exercise its Call Option on or before
              November 10, 2002, then this Agreement shall terminate and Note
              Holder's note dated 12-18-98 in the original principal balance of
              $735,000.00 shall be returned to Note Holder. Notwithstanding the
              failure by Continuum to exercise its Call Option, the Note
              Holder's note dated 12-18-98 in the original principal balance of
              $735,000.00, as well as the right to reimbursement for the
              Expenses, shall remain in full force and effect.

         d.   Any portion of the note dated 12-18-98 in the original principal
              balance of $735,000.00 and Expenses note converted and sold on or
              before November 10, 2002 shall be immediately due and payable upon
              sixty (60) days notice by Note Holder to the Corporation after
              November 10, 2002.

         e.   For purposes of this Agreement, the Escrow Agent shall be Neal &
              Associates Attorneys, 6200 Antioch Street, Suite 202, Oakland,
              California 94611.

3.       INTEREST PAYMENTS. From the Effective Date of this agreement, the
         Corporation shall continue to pay monthly interest on the note dated
         12-18-98 in the original principal balance of $735,000.00 and Expenses
         and rents due to Note Holder in the normal course of business, provided
         that all interest and rents shall be paid on the first of the month and
         received no later than the tenth (10th) of the month. If any payment is
         not received by the tent (10th) of the month, Note Holder may send a
         letter by certified mail to the Corporation demanding the late
         payment(s). If all late payments are not received within ten (10) days
         of the date of the letter, the Corporation shall be deemed to be in
         default. In such event, the total sum of principal and accrued interest
         of the note dated 12-18-98 in the original principal balance of
         $735,000.00 and Expenses shall become immediately due and payable at
         the option of the Note Holder.

4.       CASH CONSIDERATION. In consideration for this Agreement, on or before
         the Effective Date the Corporation shall make a cash payment of
         approximately $440,074.25 to pay in the full the unpaid principal
         balance and all accrued unpaid

                                       2
<PAGE>

         interest owing on the note dated 6-10-99 in the original principal
         amount of $300,903.25 (principal balance $300,903.25) and the note
         dated 9-01-00 in the original principal amount of $189,000.00
         (approximate principal balance $143,171). The Corporation shall be
         deemed to be in default if the cash payment is not received within ten
         (10) days of the Effective Date. If the payment is not received within
         ten (10) days of the Effective Date, Note Holder may send a letter by
         certified mail to the Corporation demanding the late payment. If the
         late payment is not received within ten (10) days of the date of the
         letter, the total sum of principal and accrued interest of the
         Promissory Notes and Expenses shall become immediately due and payable
         at the option of the Note Holder.

5.       LOCK-UP. Note Holder agrees to execute a lock-up agreement with all
         other officers and directors of the Corporation, at equal terms for all
         officers and directors and no longer than the shortest lock-up period
         applicable to any equity held by any other officer or director, as
         negotiated by the Corporation's Securities counsel on behalf of the
         officers and directors.

6.       REGISTRATION. The Corporation agrees to grant piggy-back registration
         rights on the Note Holder's Converted Common Shares issued in
         conjunction with, and exercisable upon, Continuum's exercise of its
         Call Option.

7.       CALL. Upon the Effective Date, Continuum shall have the absolute right,
         subject only to the provisions of the Florida General Corporation Law
         and to any other applicable restrictions on the right of a shareholder
         to sell its own shares, exercisable at any time on or before November
         10, 2002, to purchase the substituted shares selected by Note Holder in
         place of the Note Holder's Converted Common Shares, as provided inP. 8
         herein, for $2.25 per share, subject to the conditions set forth in
         this Agreement. The conversion of the Note Holder's note dated 12-18-98
         in the original principal balance of $735,000.00 and Expenses shall
         take place immediately prior to the purchase of the Note Holder's
         shares by Continuum Capital Partners, or the prorata amount at the time
         of such purchase as selected by Note Holder. Note Holder's shares will
         be the first sold by Continuum Capital Partners at the price of $2.25
         per share. In the event that Continuum has not exercised its Call
         Option, or has not paid Note Holder in full for all Shares pursuant to
         exercise of its Call Option, as of November 10, 2002, any remaining
         portion of the note dated 12-18-98 in the original principal balance of
         $735,000.00 and Expenses shall be immediately due and payable upon
         sixty (60) days notice by Note Holder to the Corporation.

8.       SHARES. Note Holder shall be allowed to substitute one cent par value
         common stock of the Corporation currently held by him for the Converted
         Common Shares called by Continuum pursuant to the Call Option granted
         in this Agreement.

9.       ASSIGNMENT. Neither this Agreement, nor any right or interest herein,
         may be sold, assigned, or otherwise transferred, voluntarily or
         involuntarily by the Note Holder, whether pursuant to any law governing
         bankruptcy or insolvency or otherwise, except that, (a) for purposes
         hereof, the personal representative

                                       3
<PAGE>

         (including a successor trustee to any trust described in clause (b)of
         this paragraph) of a deceased Note Holder and the heirs of such
         deceased Note Holder, whether by intestate succession or testamentary
         instrument, shall be deemed a "Note Holder", and (b) Note Holder may
         assign his rights under this Agreement to the trustee under a trust
         described in Subpart E of Part 1 of Subchapter J of Subtitle A of the
         Internal Revenue Code of 1986, as amended.

10.      EXERCISE OF CALL OPTION. Continuum shall exercise its Call Option by
         execution and tender to Note Holder of notice in the following form:

              Notice is hereby given that the undersigned exercises its right to
              call ________________ [number] shares in OnCure Technologies
              Corp., in accordance with the terms of that Call Option granted to
              it by Note Holder John J. Fuery in the CONVERSION OF NOTE AND
              OPTION TO SELL STOCK IN ONCURE TECHNOLOGIES CORP. Agreement
              effective May 10, 2001.

11.      EXERCISE PRICE. Continuum shall purchase the shares for $2.25 per share
         pursuant to its Call Option on or before November 10, 2002.

12.      PAYMENT OF EXERCISE PRICE. Payment of the exercise price shall be made
         within ten (10) business days following the exercise of the Call
         Option.

13.      EXPENSES. The Corporation shall bear one-half of the Note Holder's
         legal expenses through April 13, 2001 (total legal expenses on this
         matter through April 13, 2001 are $13,550.00) and all of the legal
         expenses of the preparation of this Agreement by Neal & Associates
         Attorneys. The Corporation shall pay its portion of the fees and costs
         owing to Neal & Associates immediately upon execution of this Agreement
         by all parties. The Corporation shall bear all commission and other
         related expense of the sale or redemption of any of the Note Holder's
         Converted Common Stock.

14.      NOTICES. All notices and other communications given or made pursuant
         hereto shall be in writing and shall be deemed duly given if (and then
         two business days after) made in writing and sent by registered or
         certified mail (postage prepaid, return receipt requested) to the
         parties at the following addresses:

                 --------------------------------------------------------
                 To Note Holder:       John J. Fuery, M.D.
                                       44 Farragut Ave.
                                       Piedmont, CA 94610
                                       Telephone:  1-888-377-1012
                 --------------------------------------------------------

                 --------------------------------------------------------
                 With a copy to:       Howard D. Neal, Esq.
                                       Neal & Associates Attorneys
                                       6200 Antioch St., Suite 202
                                       Oakland, CA  94611
                                       Telephone:  510-339-0233
                                       Telecopy:  516-339-6672
                 --------------------------------------------------------

                                       4
<PAGE>

                 --------------------------------------------------------
                 --------------------------------------------------------
                 To OnCure:            700 Ygnacio Valley Road, Suite 300
                                       Walnut Creek, CA 94596
                                       Telephone: 925-279-2273
                                       Telecopy: 925-274-0238
                 --------------------------------------------------------
                 --------------------------------------------------------
                 With a copy to:       Robert W. Crabtree, Esq.
                                       Crabtree, Schmidt, Zeff & Jacobs
                                       1100 14th Street, Second Floor
                                       Modesto, CA  95354
                                       Telephone:  209-522-5231
                                       Telecopy:  209-526-0632
                 --------------------------------------------------------
                 --------------------------------------------------------
                 To Continuum:         Continuum Capital Partners
                                       Attention:  Robert McCann
                                       12147 Rosedale Terrace
                                       Boynton Beach, Florida  33437
                                       Telephone:  561-364-7435
                                       Telecopy:  561-364-4252
                 --------------------------------------------------------

         or to such other persons or at such other addresses as shall be
         furnished by any party by like notice to the others. Any party may give
         notice and other communications hereunder using any means (including
         personal delivery, expedited courier, messenger service, telecopy,
         telex, or ordinary mail) but no such communication shall be deemed to
         have been duly given unless and until it actually is received by the
         individual for whom it was intended.

15.      OTHER DOCUMENTS. Each of the parties to this Amendment agrees to
         execute and deliver, at the request of the other parties, any and all
         other documents or other written instruments as may be reasonably
         necessary to effectuate the purposes of this Agreement.

16.      COUNTERPARTS. This Agreement may be executed in any number of
         counterparts, each of which may be executed by less than all of the
         parties, each of which shall be enforceable against the parties
         actually executing such counterparts, and all of which together shall
         constitute one instrument.

17.      ENTIRE AGREEMENT. This instrument constitutes the entire agreement
         between the parties relating to the Conversion of the Promissory Notes
         and Expenses and the Call Option. Any prior agreements, promises,
         negotiations, or representations not expressly set forth in this
         Agreement are of no force or effect. Any amendment to this Agreement
         shall be of no force and effect unless it is in writing and signed by
         all parties.

18.      ARBITRATION. Any dispute between the parties arising out of this
         Agreement shall be submitted to final and binding arbitration in Contra
         Costa County, California,

                                       5
<PAGE>

         under the Commercial Arbitration Rules of the American Arbitration
         Association then in effect, upon written notification and demand of
         either party therefor. In the even either party demands such
         arbitration, the American Arbitration Association shall be requested to
         submit a list of prospective arbitrators consisting of persons
         experienced in matters involving general business contracts. In making
         the award, the arbitrator shall award recovery of costs and expenses of
         the arbitration and reasonable attorneys' fees to the prevailing party.
         Any award may be entered as a judgment in any court of competent
         jurisdiction. Should judicial proceedings be commenced to enforce or
         carry out this provision or any arbitration award, the prevailing party
         in such proceedings shall be entitled to reasonable attorneys' fees and
         costs in addition to other relief. Either party shall have the right,
         prior to receiving an arbitration award, to obtain preliminary relief
         from a court of competent jurisdiction to (a) avoid injury or prejudice
         to that party; or (b) to protect the rights of any party. The parties
         agree that venue for any judicial proceeding respecting or arising out
         of this Agreement shall be in Contra Costa County, California.

19.      GOVERNING LAW. The terms of this Agreement shall be governed by the
         laws of the State of Florida, without reference to any provisions for
         choice of law.

         IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date and year first above written.

         THE CORPORATION                               THE NOTE HOLDER
         OnCure Technologies Corp.
         a Florida corporation                         /s/ John J. Fuery
                                                       -----------------
                                                       John J. Fuery, M.D.
         By: /s/ Jeffrey A. Goffman
             ----------------------
             Jeffrey A. Goffman,
             Chief Executive Officer

         CONTINUUM
         Continuum Capital Partners

         By: /s/ Robert McCann
             -----------------
             Robert McCann,
             Managing Partner

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]